Connection
Search Results to Rangaraj Selvarangan
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Selvarangan, Rangaraj
Property | Value |
research overview
|
Dr. Selvarangan is the Director of the Clinical Microbiology and Molecular Infectious Diseases Laboratory in Children’s Mercy Hospital accredited by College of American Pathologists. He has more than fifteen years of experience with directorship of high complexity clinical laboratory testing and research in the area of laboratory test evaluation and selection for implementation in routine clinical care. His research area encompasses advanced diagnostics for infectious diseases, epidemiology of infections in children, vaccine related studies, biomarker discovery and host response to infections and interventions to improve patient care and outcomes. His clinical research experience also includes federal funding and more than 100 clinical trials supported by In vitro diagnostic industry. His research team specializes in large volume prospective enrollment of children in clinical trials for infectious diseases in outpatient and inpatient settings. As the founding Principal Investigator of Kansas City-New Vaccine Surveillance Network (KC-NVSN) program since 2009, sponsored by Centers for Disease Control and Prevention, he has direct working knowledge on establishment and collaboration of multisite national networks.
|
One or more keywords matched the following items that are connected to
Selvarangan, Rangaraj
Item Type | Name |
Concept
|
Kansas
|
Academic Article
|
Molecular epidemiology and clinical presentation of human adenovirus infections in Kansas City children.
|
Academic Article
|
Human parechovirus in respiratory specimens from children in Kansas City, Missouri.
|
Academic Article
|
Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014.
|
Academic Article
|
Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA.
|
Academic Article
|
Neutralizing Antibody against Enterovirus D68 in Children and Adults before 2014 Outbreak, Kansas City, Missouri, USA1.
|
Grant
|
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
|
Academic Article
|
Nearly Complete Genome Sequences of 17 Enterovirus D68 Strains from Kansas City, Missouri, 2018.
|
Academic Article
|
Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016.
|
Grant
|
Enhanced Surveillance for New Vaccine Preventable Diseases
|
Academic Article
|
Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA.
|
Academic Article
|
Prevalence and clinical presentation of EV-D68 infections in Kansas City children during the 2022 season.
|